RxDoctor Payments Data

Amanda Hill, MD

Dermatology · Nellis Afb, NVNPI 1801238852

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.0% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 27.3% of the total.

$5,297in general payments, 2019–2025

Across 202 payments — averaging $26.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Regeneron Healthcare Solutions, Inc.$424
  • Galderma Laboratories, L.p.$403
  • Johnson & Johnson$354
  • Pfizer$269
  • Novartis$234
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$5,08596%
  • Education$2124%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,297 in reported general payments places this provider in the 55th percentile of 78 dermatology providers in Nevada.

See all dermatology providers in Nevada

Medicare billing

Part B allowed, 2024
$94,467
Medicare patients
258
Services billed
1,882

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab11$40,730
Clobetasol Propionate72$2,101
Ketoconazole67$1,063
Triamcinolone Acetonide99$974
Fluorouracil16$862
Ciclopirox17$673
Metronidazole14$468
ValacyclovirValacyclovir Hcl23$350
Doxycycline Hyclate34$335
Hydrocortisone62$274
Cefadroxil19$128
Mupirocin16$83

Paid to pharmacies, not to this prescriber.

Other dermatology in Nellis Afb

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →